Back to all studies
RecruitingNCT05384392

Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in people with a First Psychotic Episode

This study is recruiting. It focuses on schizophrenia and currently lists participation information in France.

SchizophreniaBiologicalFrom 15 Years to 30 Years
In plain English

Key information made simple

What is this study testing?

This study is testing whether a blood test or biomarker may be useful for people experiencing schizophrenia.

What would participation involve?

Participants may complete a blood test or biomarker, take part in interviews, attend study visits with the research team. The registry lists locations in France.

Who is it mainly for?

This study appears to be mainly for people with schizophrenia.

What should you check before joining?

Ask about whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: March 27, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
217
Sponsor
University Hospital, Brest
Sponsor type
Hospital / academic medical center
Study type
Biological
Intervention type
BIOLOGICAL, OTHER
Study phase
Not clearly listed
Locations
France
Age range
From 15 Years to 30 Years
Official registry ID
NCT05384392
Official title
Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

France · 5 sites
  • Dr Efflam BREGEON
    Angers
    Site status: Recruiting
  • Dr Florian STEPHAN
    Brest
    Site status: Recruiting
  • Dr Anne SAUVAGET
    Nantes
    Site status: Not Yet Recruiting
  • Dr Dominique DRAPIER
    Rennes
    Site status: Recruiting
  • Dr Vincent CAMUS
    Tours
    Site status: Recruiting

Want help reviewing this study?

Loading the security check...
Study ID: NCT05384392. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring observational follow-up for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve biological samples, imaging, or biomarkers?

This appears to be a biological / biomarker / imaging study involving Recorded interview, Clinical scales, Blood sample. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 15 Years to 30 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to provide biological samples, complete lab tests, or take part in imaging or measurement procedures. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What should I check about samples, imaging, data, and possible discomfort?

If the study involves samples, imaging, or biomarkers, ask what is collected, how it is stored, who can access results, whether there may be discomfort, and whether results are shared with you. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by University Hospital, Brest, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as recruiting. Individual sites may have different statuses. The research team must confirm whether a site is open and whether you meet the criteria.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me